Chargement en cours...

Author response to Colle et al

The event of pseudoprogression is rare in patients with MSI-high metastatic colorectal cancer receiving immune checkpoint inhibitors. In this response to the Letter to the Editor by Colle et al, we highlight that the timing of disease re-assessment may influence the incidence of pseudoprogression, w...

Description complète

Enregistré dans:
Détails bibliographiques
Publié dans:J Immunother Cancer
Auteurs principaux: Fucà, Giovanni, Corti, Francesca, Pietrantonio, Filippo
Format: Artigo
Langue:Inglês
Publié: BMJ Publishing Group 2021
Sujets:
Accès en ligne:https://ncbi.nlm.nih.gov/pmc/articles/PMC8231051/
https://ncbi.nlm.nih.gov/pubmed/34162717
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1136/jitc-2021-003138
Tags: Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!